文献速递甲状腺疾病

靶向海马内亚临床及显性甲状腺功能减退症的表现

Targeting the Manifestations of Subclinical and Overt Hypothyroidism Within the Hippocampus.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

本文解读Zhang等发表在JCEM的研究,该研究采用自动海马分割和连接分析,发现甲状腺功能减退患者记忆评分低于对照且部分海马亚区体积更小,亚临床甲状腺功能减退症(SCH)效应强于显性甲状腺功能减退症(OH),作者提出两种假说解释SCH的独特脑表现。

要点

  • 甲状腺功能减退患者记忆评分显著低于健康对照,部分海马亚区体积更小。
  • SCH组上述效应强于OH组,且两组海马亚区与额叶连接模式不同。
  • 作者假设SCH为独立临床实体,涉及脑屏障转运体缺陷或血脑屏障血管单元神经退行性变。

核心结论

  • SCH可能代表一种具有独特脑表现的独立临床实体。
  • 作者提出两种假说解释SCH的脑表现:脑屏障转运体缺陷和血脑屏障血管单元差异性神经退行性变。

研究设计与样本

  • 本文为对Zhang等发表于JCEM研究的解读,原文研究纳入相对较大样本的OH、SCH患者和健康对照,进行全局认知功能测试及结构和功能磁共振成像。
  • 原文采用自动处理工具将海马分割为不同亚区,并进行连接分析评估特定海马亚区与皮层区域的关系。

主要发现

  • 甲状腺功能减退组在记忆量表上的得分显著低于对照组。
  • 甲状腺功能减退组在选择性海马亚区体积更小。
  • 上述效应在SCH组强于OH组。
  • SCH组和OH组在海马亚区与特定额叶区域之间的互连模式不同。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The past decade has witnessed a surge of articles describing the neurocognitive sequelae and associated structural and functional brain abnormalities of patients with overt hypothyroidism (OH) and subclinical hypothyroidism (SCH). Findings show effects primarily within the frontal lobes with usually worse outcomes for OH than SCH. Several recent studies have also indicated hypothyroid patients may have smaller hippocampi, a key structure for memory. CONTEXT: The JCEM paper by Zhang and colleagues applies 2 novel approaches for analyzing hippocampal structure and function. One uses an automated processing tool that segments the hippocampus into distinct subregions, and the other performs connectivity analysis to assess the relationships between specific hippocampal subregions and cortical areas. Relatively large samples of OH and SCH patients and healthy controls received a test of global cognitive functioning and underwent structural and functional magnetic resonance imaging. Results showed hypothyroid groups scored significantly below controls on the memory scale and also had smaller hippocampal volumes in selective subregions. Effects were stronger for SCH than OH groups, who also showed different patterns of interconnectivity between hippocampal subregions and specific frontal lobe areas. INTERPRETATION: To make sense of these findings, I explored the rodent and human literatures on thyroid hormone's role in hippocampal functioning and on hippocampal subfields and their purported functions and interconnections. Because current results suggest SCH may represent a distinct clinical entity with unique brain manifestations, I hypothesized 2 explanations for these findings, one involving transporter defects in the brain barriers and the other, differential neurodegeneration of the blood-brain barrier vascular unit.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Rovet JF. Targeting the Manifestations of Subclinical and Overt Hypothyroidism Within the Hippocampus. J Clin Endocrinol Metab. 2024. PMID: 38970545. doi:10.1210/clinem/dgae453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。